<DOC>
	<DOCNO>NCT01295710</DOCNO>
	<brief_summary>The study objective compare efficacy safety US-ATG-F supplement standard care prophylaxis versus standard care prophylaxis alone moderate severe chronic GVHD-free survival .</brief_summary>
	<brief_title>Study US-ATG-F Prevent Chronic Graft Versus Host Disease ( GVHD )</brief_title>
	<detailed_description>This study randomize , prospective , double-blind , placebo-controlled , phase 3 study evaluate prevention moderate severe chronic GVHD patient undergo bone marrow peripheral blood stem cell transplantation match , unrelated donor acute leukemia myelodysplastic syndrome first year transplant . Patients meet inclusion none exclusion criterion randomize ( 1:1 ) . All patient receive premedication study drug 3 day prior transplantation .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Key Patients designate undergo allogeneic peripheral blood bone marrow stem cell transplantation follow diagnosis one primary diseases early intermediate disease status ( i.e. , acute myeloid leukemia , acute lymphoid leukemia , myelodysplastic syndrome ) Patients unrelated HLAA , B , C DRBI match donor Patients Karnofsky Performance Score â‰¥ 70 % Key Clinically significant concomitant disease ( i.e. , cardiac , pulmonary , renal CNS ) Bacterial , viral , fungal infection Known positive Hepatitis B surface antigen , Hepatitis C antibody , test positive HIV Patients concurrent malignancy . Cancer treat curative intent &lt; 5 year previously allow except patient resect basal cell carcinoma treat cervical carcinoma situ Known contraindication administration rabbit immunoglobulin antibody Hypersensitivity methylprednisolone , tacrolimus , methotrexate excipients contain product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>adult acute myeloid leukemia</keyword>
	<keyword>adult acute lymphoid leukemia</keyword>
	<keyword>adult myelodysplastic syndrome</keyword>
	<keyword>allogenic stem cell transplantation</keyword>
	<keyword>unrelated donor</keyword>
	<keyword>GVHD</keyword>
	<keyword>US-ATG-F ( Anti-human-T-lymphocyte Immune Globulin , Rabbit )</keyword>
</DOC>